Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells

Abstract

Hematopoietic stem cells (HSCs) repopulate the immune system during normal replenishment as well as under the burden of pathogen stress, but the respective outcomes of differentiation are not the same. Under homeostatic conditions such as those which accompany turnover of immune cell subsets, HSCs appear to co-equally prime genes associated with the major downstream lineages: lymphoid, myeloid, and megakaryocyte/erythroid. Recent studies reveal, however, that during pathogen exposure, hematopoiesis may yield progeny in proportions different than those produced under homeostasis. At least some of these effects may be due to pathogen engagement of Toll-like receptors (TLRs) expressed on HSCs. HSCs are also responsive to inflammatory cytokines that are produced in response to pathogen burden and are present in the bone marrow microenvironment. Thus, hematopoiesis is not a formulaic process that produces the same, predictable outcome regardless of the specific environmental context. Rather, hematopoiesis represents a dynamic biological system that can be appreciably responsive to environmental factors, an influence that extends to the level of the HSC itself. Knowledge of functional consequences of TLR ligation on HSCs may be therapeutically exploited and applied to treatment of hematopoietic insufficiency in the setting of infection and disease.

Mesenchymal Stromal Cell-derived Extracellular Vesicles Promote Myeloid-biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement

“…Recent studies indicate that HSPC self-renewal and emergence from quiescence are also regulated by type I and II interferons as well as Toll-like receptors (TLRs), signals associated with innate immunity (7-10), and known to contribute to regenerative HSPC responses (11)(12)(13)(14)(15). TLR signaling involves a number of transmembrane receptors and several critical adaptor molecules (16).…”

“…Evidence supports TLR activation in the HSPC response to diverse stimuli, including radiation, bleeding, and infection (reviewed in Ref. 12). More recent reports, however, indicate that these mechanisms are also relevant for "tonic" homeostatic function and as well as developmental emergence of HSPCs (15,17,18).…”

“…Cell fate commitment yields a cascade of successively more restricted progenitor populations that give rise to circulating blood and mature immune cells (2). HSPC activation relies on cell-autonomous programs as well as extrinsic cues from the surrounding bone marrow microenvironment where mesenchymal stromal cells, osteoprogenitors, and endothelial cells act through the paracrine action of secreted cytokines and angiogenic factors (3-6).Recent studies indicate that HSPC self-renewal and emergence from quiescence are also regulated by type I and II interferons as well as Toll-like receptors (TLRs), signals associated with innate immunity (7-10), and known to contribute to regenerative HSPC responses (11)(12)(13)(14)(15). TLR signaling involves a number of transmembrane receptors and several critical adaptor molecules (16).…”

Direct Toll-Like Receptor-Mediated Stimulation of Hematopoietic Stem and Progenitor Cells Occurs In Vivo and Promotes Differentiation Toward Macrophages

“…HSPCs expansion and alterations in hematopoiesis during infection have been described in several models of bacterial, viral, and fungal infection, although the contribution of TLR signaling to this phenomenon is still a matter of discussion [16,17]. Although most of the infection models demonstrate that TLR-mediated signals play an essential role in the control of HSPC expansion [6][7][8]12], other authors [18] have described that the expansion of HSPCs following bacterial infection occurs in the absence of TLR signaling.…”

“…However, hematopoiesis can be dramatically altered during infections, which influence numbers and types of cells that are produced. During most bacterial, viral, and fungal infections, myelopoiesis becomes predominant with inhibition of other lineage (lymphoid and erythroid) development, and this is accompanied by alterations of the cellular composition and/or phenotype of bone marrow HSPCs [16,17].…”